PMID: 11344042May 10, 2001Paper

A review of the genotoxicity of marketed pharmaceuticals

Mutation Research
R D Snyder, J W Green

Abstract

Information in the 1999 Physician's Desk Reference as well as from the peer-reviewed published literature was used to evaluate the genotoxicity of marketed pharmaceuticals. This survey is a compendium of genotoxicity information and a means to gain perspective on the inherent genotoxicity of structurally diverse pharmaceuticals. Data from 467 marketed drugs were collected. Excluded from analysis were anti-cancer drugs and nucleosides, which are expected to be genotoxic, steroids, biologicals and peptide-based drugs. Of the 467 drugs, 115 had no published gene-tox data. This group was comprised largely of acutely administered drugs such as antibiotics, antifungals, antihistamines decongestants and anesthetics. The remaining 352 had at least one standard gene-tox assay result. Of these, 101 compounds (28.7%) had at least one positive assay result in the pre-ICH/OECD standard four-test battery (bacterial mutagenesis, in vitro cytogenetics, mouse lymphoma assay (MLA), in vivo cytogenetics). Per assay type, the percentage of positive compounds was: bacterial mutagenesis test, 27/323 (8.3%); in vitro cytogenetics 55/222 (24.8%); MLA 24/96 (25%); in vivo cytogenetics 29/252 (11.5%). Of the supplemental genetic toxicology test findings...Continue Reading

References

Mar 1, 1992·Risk Analysis : an Official Publication of the Society for Risk Analysis·W W PiegorschD G Hoel
Oct 3, 1998·Mutation Research·L BroschinskiC Hensel
Mar 29, 2000·Environmental and Molecular Mutagenesis·L Müller, T Sofuni

❮ Previous
Next ❯

Citations

Mar 5, 2003·Teratogenesis, Carcinogenesis, and Mutagenesis·Jane S AllenAnn D Mitchell
Feb 18, 2011·Archives of Toxicology·Giovanni BrambillaAntonietta Martelli
Jan 22, 2011·Cytotechnology·Umit ZanErman Salih Istifli
Nov 14, 2002·Biochemical Pharmacology·Paola PoliTânia Maria Araújo Domingues Zucchi
Sep 27, 2005·Drug Discovery Today·Ronald D Snyder, Mark D Smith
Jul 28, 2012·Journal of Chemical Information and Modeling·Yong WangKaixian Chen
Jun 2, 2010·Nature Reviews. Drug Discovery·Federico M GoodsaidIssam Zineh
Jan 20, 2009·The Journal of Antimicrobial Chemotherapy·André C AmaralMaria Sueli S Felipe
May 19, 2010·Mutagenesis·Giovanni BrambillaAntonietta Martelli
Feb 19, 2008·Toxicological Sciences : an Official Journal of the Society of Toxicology·Mark R FieldenUNKNOWN Carcinogenicity Working Group
May 26, 2009·Toxicological Sciences : an Official Journal of the Society of Toxicology·Heidrun Ellinger-ZiegelbauerJiri Aubrecht
Jul 16, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Madhu S MondalPhilip Bentley
Dec 15, 2010·Environmental Health Perspectives·Richard S PaulesJos C Kleinjans
Apr 1, 2009·Genetics and Molecular Biology·Adekunle A BakareHafeez B Jenmi
Apr 1, 2010·Toxicology and Applied Pharmacology·Weihsueh A ChiuRavi P Subramaniam
Jul 19, 2014·Environmental Toxicology and Pharmacology·Goran GajskiVera Garaj-Vrhovac
Mar 20, 2014·Drug and Chemical Toxicology·Seval Kontaş, Zülal Atlı Şekeroğlu
May 5, 2004·Journal of Pharmaceutical Sciences·Lucila C M EgitoE Sócrates T Egito
Jan 18, 2016·Mutation Research. Genetic Toxicology and Environmental Mutagenesis·David KirklandRaffaella Corvi
Dec 25, 2012·Mutation Research·P A EscobarB Mahadevan
Oct 5, 2011·Mutation Research·Giovanni BrambillaAntonietta Martelli
Jan 5, 2011·Journal of Pharmaceutical and Biomedical Analysis·N V V S S RamanK Ratnakar Reddy
Dec 23, 2009·Toxicology in Vitro : an International Journal Published in Association with BIBRA·H MaeshimaT Yamada
Jul 28, 2009·Mutation Research·Lya G HernándezJan van Benthem
May 5, 2009·Toxicology·Giovanni BrambillaAntonietta Martelli
Jan 20, 2016·BioMed Research International·Rodrigo Pinheiro AraldiRita de Cassia Stocco
Oct 11, 2008·Mutation Research·Giovanni Brambilla, Antonietta Martelli
Sep 30, 2008·Toxicology Letters·Heidrun Ellinger-ZiegelbauerHans-Juergen Ahr
Mar 11, 2008·Chemico-biological Interactions·Paul NioiRonald D Snyder

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.